GS3-007a Oral Solution in Healthy Subjects

Phase I Randomized, Double-blind, Placebo-controlled, Single Multiple Dosing, Dose Escalation, and Food Effect Study of GS3-007A Oral Liquid in Chinese Healthy Adults

To evaluate the safety and tolerability of GS3-007A in single, multiple, and single oral administration after high-fat meals in Chinese healthy adults.

This is a first-in-human, The major aims of the study are to define the safety profile of this new drug, and to determine a recommended

Inclusion Criteria:

• Healthy adult subjects aged 18-45 years (including boundary values), male and female;
• Body mass index: 19-26 kg/m2 (including boundary value), male weight ≥50 kg, female weight ≥45 kg;

Exclusion Criteria:

• Patients with a history of substance abuse and substance dependence;
• Family history of sudden death;